Healthcare Services - Diversified Hospital and Outpatient Care
Strategic Profile
The company is executing a strategic pivot toward higher-margin ambulatory surgery centers while keeping its hospital footprint productive. In February 2026, Tenet reported Q4 2025 results that beat earnings and revenue expectations, with 2026 consolidated guidance for net operating revenues of $21.50–$22.30 billion and net income of $2.61–$2.84 billion.
Cyborg Score Rationale
Q4 2025 beat, sharp lift in 2026 net income guidance to $2.61–$2.84 billion, and completed buyback of over 10% of shares reinforce management's strategic shift gaining traction. However, high debt load and margin pressures remain risks to monitor.
Top Insights
Analysts rate Tenet Healthcare as Buy with 17 analysts providing this consensus as of February 13, 2026.
Key catalysts include execution on ambulatory growth, integration of recent facility additions, and updates around the Conifer transaction with CommonSpirit.
Heavy debt financing, volatile profit margins, and recent insider selling remain governance risks.
THC stock has risen 73.24% over the past year.
Named Competitors
HCA Healthcare — Large for-profit hospital system with extensive acute care network
Community Health Systems — Regional healthcare provider with hospital and outpatient network
Ambulatory Surgery Centers — Competitor in high-margin ambulatory surgical services
Recent Developments
(February 2026) Q4 2025 earnings beat and 2026 guidance raise with net income outlook of $2.61–$2.84 billion
(February 2026) Completed Conifer Health Solutions transaction with CommonSpirit Health
(February 2026) UBS raised price target to $288, analyst upgrades support continued upside
Open the full interactive Tenet Healthcare Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.